ATEC says procedural volumes and surgeon adoption drive strong growth
Alphatec says procedural volumes and surgeon adoption are driving strong growth, and that it has reaffirmed guidance for revenue, EBITDA and free cash flow. It cites product innovation in Valence and EOS Insight and the Theradaptive acquisition.